Current diagnostic tools often fall short due to a lack of sensitivity and specificity. For instance, traditional imaging methods like X-rays and CT scans can fail to detect small or early-stage tumors. Similarly, blood tests may not always indicate the presence of cancer, or they may produce false positives and negatives. This underscores the need for more reliable biomarkers.
